AU2001259078A1 - Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene - Google Patents

Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene

Info

Publication number
AU2001259078A1
AU2001259078A1 AU2001259078A AU5907801A AU2001259078A1 AU 2001259078 A1 AU2001259078 A1 AU 2001259078A1 AU 2001259078 A AU2001259078 A AU 2001259078A AU 5907801 A AU5907801 A AU 5907801A AU 2001259078 A1 AU2001259078 A1 AU 2001259078A1
Authority
AU
Australia
Prior art keywords
gene
theraphy
vectors encoding
adenovirus vectors
pulmonary edema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259078A
Inventor
Phillip H. Factor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edema Clearance Inc
Original Assignee
Edema Clearance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edema Clearance Inc filed Critical Edema Clearance Inc
Publication of AU2001259078A1 publication Critical patent/AU2001259078A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001259078A 2000-04-18 2001-04-16 Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene Abandoned AU2001259078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22825400P 2000-04-18 2000-04-18
US60/228,254 2000-04-18
PCT/US2001/012410 WO2001078790A2 (en) 2000-04-18 2001-04-16 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE

Publications (1)

Publication Number Publication Date
AU2001259078A1 true AU2001259078A1 (en) 2001-10-30

Family

ID=22856410

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259078A Abandoned AU2001259078A1 (en) 2000-04-18 2001-04-16 Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene

Country Status (3)

Country Link
US (1) US20020004042A1 (en)
AU (1) AU2001259078A1 (en)
WO (1) WO2001078790A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2671522T3 (en) 2004-04-02 2018-06-06 The Regents Of The University Of California Methods and compositions for treating and preventing a disease associated with integrin alpha V beta 5
IN2012DN00303A (en) 2009-07-24 2015-05-08 Univ California
US10402198B2 (en) * 2013-06-18 2019-09-03 Nxp Usa, Inc. Signal processing device and method of performing a pack-insert operation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung

Also Published As

Publication number Publication date
WO2001078790A3 (en) 2002-10-31
WO2001078790A2 (en) 2001-10-25
US20020004042A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
AU5043900A (en) Adenovirus vectors encoding brain natriuretic peptide
AUPQ841800A0 (en) Truncated egf receptor
AU2002250067A1 (en) All fiber polarization mode dispersion compensator
EP1423113A4 (en) Nr1h4 nuclear receptor binding compounds
AU2002346582A1 (en) Spread-style implement coupler for construction machines
AU2001292547A1 (en) Polarization mode dispersion compensator based on rotating micro-mirrors
AU2001262950A1 (en) All fiber polarization mode dispersion compensator
EP1100896A4 (en) Dna encoding snorf33 receptor
AU2001259078A1 (en) Gene theraphy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene
AU2002351264A1 (en) System for polarization mode dispersion compensation
AU2001229728A1 (en) Replication deficient adenovirus vectors
AU2002332736A1 (en) New adenovirus type 7 vectors
AU2001263164A1 (en) Flexible job delivery for job preparation
AU2001223882A1 (en) Receptor
AU2001297554A1 (en) Polishing chemical delivery for small head chemical mechanical planarization
AU1252102A (en) Receptor
AU2001241299A1 (en) Spacer for laying floors
AU2001294619A1 (en) Adp-glucose receptor
AU2002360557A1 (en) Dna encoding orphan snorf49 receptor
AU5934800A (en) Dna encoding orphan snorf40 receptor
AUPQ578100A0 (en) A flooring slab
AU2002319806A1 (en) Nr1h4 nuclear receptor binding compounds
AU2002329243A1 (en) Nr1h4 nuclear receptor binding compounds
AU2002310218A1 (en) Replicating adenovirus vectors